Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Thu, 21st Nov 2019 12:56

(Alliance News) - Faron Pharmaceuticals Oy on Thursday said it has applied to list is shares on Nasdaq First North Growth Market.

Faron's shares are currently traded on London's AIM market via depositary interest, and these were up 9.8% at 195.50 pence on Thursday afternoon.

Nasdaq First North Growth is a multilateral trading facility and is operated by Nasdaq Helsinki Ltd, it is intended to help Nordic and international companies to increase investor visibility in preparation for a listing on the regulated Nasdaq Main Market.

Should the application prove successful, clinical stage biopharmaceutical firm Faron expects its first day of Nasdaq First North trading to be December 3.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Related Shares

More News

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

29 Nov 19 10:23

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

28 Nov 19 11:56

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

21 Nov 19 12:56

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

8 Nov 19 10:30

Login to your account

Don't have an account? Click here to register.